Genomik Solidaritas Indonesia (GSI Lab)

GSI Lab is established to help Indonesia control COVID-19. Currently, it is focusing on a high-throughput PCR diagnostic laboratory with a capacity of up to 5,000 tests per day, the biggest in Indonesia. GSI Lab is powered by highly trained staff, automated PCR equipment, and digital systems for maximum accuracy and large-capacity same-day results, if needed. GSI Lab re-invests profits to further amplify our vision and mission.

GSI Lab plans to expand its solutions, beyond COVID-19, e.g. HIV, hepatitis, malaria, anthrax and other tropical diseases, to address the most pressing challenges at the national and global level for better equity and thriving societies.
GSI goals is to build networks that brings people together to solve the most pressing issues in the world, including public health

Organisation Representative

Jen Santos

Program Director

Based In

Market Active

Social causes

Beneficiaries

Support Provided

Non-Financial

Access to Networks, Other(s), Research, Use of Facilities

Get in Touch

Not a member yet? Become an AVPN member.

Some of our notable members

Stay updated. Sign up for the #1 newsletter on social investment in Asia.

This field is for validation purposes and should be left unchanged.

©2021 Asian Venture Philanthropy Network | AVPN is registered in Singapore as a charity (UEN 201016116M)